SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

16 May 2023 Evaluate
The Revenue for the quarter ended  March 2023 of Rs. 10138.75 millions grew by 11.07 % from Rs. 9128.48 millions.A slender decline of -3.06% was recorded to Rs. 1252.89  millions from Rs. 1292.44 millions in the corresponding previous quarter.Operating Profit saw a handsome growth to 2198.57 millions from 2102.48 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 10138.75 9128.48 11.07 39312.00 32384.37 21.39 39312.00 32384.37 21.39
Other Income 25.61 42.79 -40.15 99.32 175.11 -43.28 99.32 175.11 -43.28
PBIDT 2198.57 2102.48 4.57 8481.71 6621.60 28.09 8481.71 6621.60 28.09
Interest 141.19 40.01 252.89 386.74 163.52 136.51 386.74 163.52 136.51
PBDT 2057.38 2062.47 -0.25 8094.97 6458.08 25.35 8094.97 6458.08 25.35
Depreciation 377.69 316.83 19.21 1455.57 1261.61 15.37 1455.57 1261.61 15.37
PBT 1679.69 1745.64 -3.78 6639.40 5196.47 27.77 6639.40 5196.47 27.77
TAX 426.80 453.20 -5.83 1651.55 1331.31 24.05 1651.55 1331.31 24.05
Deferred Tax 12.34 11.44 7.87 -50.51 -3.76 1243.35 -50.51 -3.76 1243.35
PAT 1252.89 1292.44 -3.06 4987.85 3865.16 29.05 4987.85 3865.16 29.05
Equity 242.04 248.01 -2.41 242.04 248.01 -2.41 242.04 248.01 -2.41
PBIDTM(%) 21.68 23.03 -5.85 21.58 20.45 5.52 21.58 20.45 5.52

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×